Zymeworks ZYME
NASDAQ ZYME
$26.95 -0.25 (-0.92%)
As of: Sep 30, 2026 · 9:40 AM EDT

Zymeworks (ZYME) Other financing activities (2024 - 2026)

Updated

Zymeworks (ZYME) recorded Other financing activities of $250 million in Q1 2026.

Analysis

Zymeworks (ZYME) Other financing activities (2024 - 2026) Analysis & Trends

Starting with Q3 2024, Zymeworks' Other financing activities history includes 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Zymeworks 1.94 Bn 820.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 250.00 Mn
Sep 30, 2025 28,000.00
Jun 30, 2025 65,000.00
Sep 30, 2024 92,000.00
API Access

Zymeworks Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ZYME&period=max&api_key=YOUR_API_KEY